Browse studies

Find your next paid study

27,300 recruiting studies available now

Health Behavior Intervention for Adults With Type 1 Diabetes

Type 1 diabetes (T1D) affects approximately 2 million Americans, and only 2 in 8 young adults ages 18-31 years achieve glycemic targets (glycated hemoglobin A1…

Type1diabetes

Estimated

~$10 – $750

Actual pay is set by the research site.

Emory UniversityNCT05823142

Observational

Modeling the Effects of Chronic Marijuana Use on Neuroinflammation and HIV-related Neuronal Injury

This study applies a hypothesis-driven approach to examine the effects of chronic marijuana use on HIV-associated inflammation and its subsequent impacts on ce…

CannabisHIVInflammation+2 more

Estimated

~$10 – $750

Actual pay is set by the research site.

Wake Forest University Health SciencesNCT04810858

Phase 4

Pilot Study of Exenatide Pharmacokinetics and Pharmacodynamics in Gestational Diabetes

This study is being done to study how exenatide, an FDA-approved drug that lowers blood sugar in non-pregnant patients with type II diabetes, works in pregnant…

Gestational Diabetes

Estimated

~$25 – $1,500

Actual pay is set by the research site.

Maisa N. Feghali, MDNCT05482789

Evaluation of Recipients With and Without Proteinuria, Pre and Post Kidney Transplantation

Patients with focal segmental glomerulosclerosis (FSGS) who progress rapidly to end stage renal disease (ESRD) are at highest risk for development of recurrenc…

Proteinuria

Estimated

~$10 – $750

Actual pay is set by the research site.

University of MiamiNCT01094327

Phase 1

Prospective Study of Complication Rates in Cataract Surgery Patients Treated With Combined Pre-operative NSAID, OMIDRIA, and Subconjunctival Triamcinolone Acetonide Compared With Peri-operative Standard of Care

This is a multicenter, 2-arm, randomized, prospective study of patients slated for bilateral cataract extraction. One eye will be randomized to the Study Arm, …

Cataract

Estimated

~$150 – $4,500

Actual pay is set by the research site.

Inder Paul Singh, M.D.NCT06681688

Observational

Adaptation and Implementation of Flourish Within Schools: Strengthening Suicide Prevention Services for Adolescents Experiencing Online Victimization

This study will test Flourish, a digital suicide prevention intervention for cyberbullied youth, within schools. Specifically, the study aims to: 1. Examine …

Psychological DistressSuicidal Ideation

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Candice BiernesserNCT07506525

Phase 1

Constitutive IL7R (C7R) Modified Banked Allogeneic CD30 Chimeric Antigen Receptor Epstein-Barr Virus-Specific T Lymphocytes (CD30.CAR-EBVSTs) in Patients With Relapsed or Refractory CD30-Positive Lymphomas

This study involves patients with diffuse large B cell lymphoma (DLBCL), natural killer/T-cell lymphoma (NKTL), or classical Hodgkin lymphoma (cHL) (referred t…

CD30-Positive Diffuse Large B-Cell LymphomaAnaplastic Large Cell Lymphoma, T Cell and Null Cell TypeAnaplastic Large Cell Lymphoma, ALK-Positive+4 more

Estimated

~$150 – $3,000

Actual pay is set by the research site.

Baylor College of Medicine

Phase 2

A Phase II Study of PET Adapted Therapy and Non-invasive Monitoring for Previously Untreated Limited Stage Diffuse Large B Cell Lymphoma

The overarching goals of this study are to measure levels of circulating tumor DNA (ctDNA) in patients with early stage diffuse large B cell lymphoma (DLBCL), …

DLBCL

Estimated

~$75 – $2,000

Actual pay is set by the research site.

University of RochesterNCT03758989

Observational

DAWGS in Time-Restricted Eating and Activity Trends (DAWG-TREAT)

Time-restricted Eating (TRE) is a dietary approach that limits food intake to 4 - 12-hour windows without intentionally altering diet quality. TRE has several …

Sleep QualityCompliancePhysical Activity+2 more

Estimated

~$10 – $750

Actual pay is set by the research site.

University of GeorgiaNCT07520786

Phase 2

A Phase II Study Using Rituximab Plus Venetoclax in the Front Line Treatment of Marginal Zone Lymphoma

The purpose of this study is to see if the combination of rituximab and venetoclax is effective in treating participants with untreated Marginal Zone Lymphoma …

LymphomaMarginal Zone LymphomaMZL

Estimated

~$75 – $3,000

Actual pay is set by the research site.

Gottfried von Keudell, MD PhDNCT06510309

Phase 1

A Phase 1 Pharmacokinetic/Bioequivalence Study of 100 Mg of HEZKUE® (ASP-001, Sildenafil) Versus 100 Mg of VIAGRA® (Sildenafil) Film-Coated Tablets Under Fasted Conditions in Healthy Adult Male Subjects

The objective of this phase 1, open-label, single-center, two-way crossover trial is to evaluate the pharmacokinetics (PK), safety, and tolerability of 100 mg …

Erectile Dysfunction

Estimated

~$500 – $10,500

Actual pay is set by the research site.

Aspargo Labs, IncNCT06782659

Phase 2

A Phase 2 Open-Label Study to Evaluate the Safety and Efficacy of DCR-PHXC in Patients With Primary Hyperoxaluria Type 1 and Severe Renal Impairment, With or Without Dialysis

The aim of this study is to evaluate DCR-PHXC in participants with PH1 and severe renal impairment, with or without dialysis.

Primary Hyperoxaluria Type 1End Stage Renal Disease

Estimated

~$75 – $2,800

Actual pay is set by the research site.

Dicerna Pharmaceuticals, Inc., a Novo Nordisk companyNCT04580420